Abstract
Blood neutrophils, when exposed to appropriate stimuli, aggregate, degranulate and generate superoxide anion. Curcumin, a non-steroidal antiinflammatory agent, modulated these functions, depending upon the kind of stimulus used. It inhibited monkey neutrophil aggregation induced by chemotactic peptide fmlp and zymosan activated plasma (ZAP) but did not affect that induced by serum treated zymosan (STZ) and arachidonic acid (AA). Generation of O −2 radical was inhibited by curcumin, when cells were stimulated by AA, STZ and fmlp. Curcumin inhibited the release of myeloperoxidase, an azurophilic granule marker enzyme. Release of lysozyme was less susceptible to inhibition by curcumin. The results suggest that curcumin interferes with neutrophil responses to various physiological stimuli and a part of its antiinflammatory action is mediated via inhibition of neutrophil function. Inhibition of neutrophil function by curcumin appears to be mediated via calcium dependent mechanisms.
Abbreviations
- NSAID:
-
Nonsteroidal antiinflammatory drug; fmlp, N-formyl-methionyl-leucyl-phenyl alanine
- PMNL:
-
polymorphonuclear leukocytes
- PMA:
-
12-O-phorbol myristateacetate
- CB:
-
Cytochalasin B (O −2 ), superoxide anion IP3, inositol 1,4,5 triphosphate
References
G. Weissmann, J. E. Smolen and H. M. Korchak,Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med.303, 27–34 (1980).
H. B. Kaplan, H. S. Edelson, R. Friedman and G. Weissmann,The roles of degranulation and superoxide generation in neutrophil aggregation. Biochem. Biophys. Acta721, 55–63 (1982).
E. L. Becker, H. J. Showell, P. M. Henson, and L. S. Hsu,The ability of chemotactic factors to induce lysosomal enzyme release I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J. Immunol.112, 2047–2054 (1974).
J. C. Fantone and P. A. Ward,Role of oxygen derived free radicals and metabolites in leukocyt dependent inflammatory reactions. Am. J. Path.107, 397–418 (1982).
J. M. Harlan,Consequences of leukocyte-vessel wall interactions in inflammatory and immune reactions. Sem. Thrombos. Haemost.123, 434–444 (1987).
S. Abramson, H. Korchak, R. Ludewig, H. Edelson, K. Haines, R. I. Levin, R. Herman, L. Rider, S. Kimmel, and G. Weissmann,Modes of action of aspirin like drugs. Proc. Natl. Acad. Sci. USA82, 7227–7231 (1985).
R. C. Srimal,Curcumin. Drugs Fut.12, 331–333 (1987).
R. Srivastava, V. Puri, R. C. Srimal, and B. N. Dhawan,Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. Arzneim. Forsch.36, 715–717 (1986).
R. Srivastava, M. Dikshit, R. C. Srimal, B. N. Dhawan,Antithrombotic effect of curcumin. Thrombos. Res.40, 413–417 (1985).
A. Boyum,Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest.21 (Suppl. 97), 77–89 (1968).
P. R. Craddock, J. Fehr, A. P. Dalmasso, K. L. Brigham and H. S. Jacob,Hemodialysis leukopenia pulmonary vascular leukostasis resulting from complement activation by dialyzer cellopnane membrane. J. Clin. Invest.59, 879–888 (1972).
B. Weisner,Lysozyme (Muramidase) in Methods Enzymatic Analysis. vol. IV. H. U. Bergmeyer (Ed.) pp. 189–195 (1984).
P. M. Henson, B. Zanolari, N. A. Schwartzman and S. R. Hong,Intracellular control of human neutrophil secretions I. C5 a induced stimulus specific desensitization and the effects of cytochalasin B. J. Immunol.121, 851–855 (1978).
H. V. Bergmeyer, E. Bernt, and B. Hess,Lactic acid dehydrogenase. InMethods of enzymatic analysis, vol. 1, H. V. Bergmeyer (Ed.), p. 481. Orlando FL, Academic 1974
B. M. Babior, R. S. Kipnes and J. T. Curnette,Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest.52, 741–744 (1973).
M. Nikishima, N. A. Rao, and K. Yagi,The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun.46, 849–854 (1972).
A. A. Abdel-Latif,Calcium mobilizing receptors polyphosphoinositides and the generation of second messengers. Pharmacol. Rev.38, 227–272, (1986).
Y. Nishizuka,The role of protein kinase C in cell surface transduction and tumour promotion. Nature308, 693–698 (1984).
M. J. Berridge, and R. F. Irvine,Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature312, 315–321 (1984).
C. D. Smith, C. C. Cox and R. Synderman,Receptor coupled activation of phosphoinositide specific phospholipase C by an N-protein. Science232, 97–99 (1986).
P. C. Andrews, and B. M. Babior,Phosphorylation of cytosolic proteins by resting and activated human neutrophils. Blood64, 883–889 (1984).
J. T. O'Flaherty, H. J. Showell, E. L. Becker, P. A. Ward,Role of arachidonic acid derivatives in neutrophil aggregation: A hypothesis. Prostaglandins17, 915–927 (1979).
P. A. J. Henricks, M. E. Vandertol, J. H. van Kats-Renaud, F. P. Nijkamp and J. Verhoef,Difference in the effect of arachidonic acid on polymorphonuclear leukocyte function. Biochim. Biophys. Acta801, 206–214 (1984).
R. J. Smith, L. M. Sam, J. M. Justen, K. L. Leach and D. E. Epps,Human polymorphonuclear neutrophil activation with arachidonic acid. Brit. J. Pharmacol.91, 641–649 (1987).
A. W. Ford Hutchinson, M. A. Bray, M. V. Doig, M. E. Shipley, and M. J. H. Smith,Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature286, 264–265 (1980).
P. J. Spagnuolo, J. J. Ellner, A. Hassid and M. J. Dunn,Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness.J. Clin. Invest. 66, 406–414 (1980).
J. A. Badwey, J. T. Curnutte, M. L. Karnovsky,Cis poly unsaturated fatty acid induce high levels of superoxide production by human neutrophils. J. Biol. Chem.256, 12640–12643 (1981).
R. Srivastava and R. C. Srimal,Modification of some inflammation induced biochemical changes by curcumin. Ind. J. Med. Res.81, 215–223 (1985).
L. Williams, R. Snyderman, M. C. Pike and R. J. Lefkowitz,Specific receptor sites for chemotactic peptide on human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U.S.A.74, 1204–1208 (1977).
E. Wilson, W. G. Rice, J. M. Kinkade, A. H. Merill R. R. Arnold and J. D. Lambeth,Phosphokinase C inhibition by sphingoloid long chain bases. Effects on secretion in human neutrophils. Arch Biochem. Biophys.259, 204–214 (1987).
S. C. Sharma, H. Mukhtar, S. K. Sharma and C. R. Krishnamurathi,Lipid peroxide formation in experimental inflammation. Biochem. Pharmacol.21, 1210–1214 (1972).
O. P. Sharma,Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol.25, 1811–1812 (1976).
S. D. Deodhar, R. Sethi and R. C. Srimal,Preliminary studies on antirheumatic activity of curcumin (diferuloyl methane) Ind. J. Med. Res.71, 632–634 (1980).
R. C. Srimal, and B. N. Dhawan,Pharmacological and clinical studies on Curcuma longa. InDevelopment of Unani Drugs from Herbal sources and the Role of Elements in their Mechanism of Action. R. A. Arora (ed.) pp. 131–142, Hamdard National Foundation, New Delhi 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Srivastava, R. Inhibition of neutrophil response by curcumin. Agents and Actions 28, 298–303 (1989). https://doi.org/10.1007/BF01967418
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01967418